DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C0025517 | Metabolic Diseases | MGAT4A | 11320 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A | Q9UM21 |
C0009404 | Colorectal Neoplasms | MGAT4A | 11320 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A | Q9UM21 |
C1135868 | Gestational Trophoblastic Neoplasms | MGAT4A | 11320 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A | Q9UM21 |
C3280795 | HYPOPLASTIC LEFT HEART SYNDROME 2 | MGAT4A | 11320 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A | Q9UM21 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | MGAT4A | 11320 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A | Q9UM21 |
C0027651 | Neoplasms | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C3887461 | Head and Neck Carcinoma | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C1306459 | Primary malignant neoplasm | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C0003864 | Arthritis | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C0006826 | Malignant Neoplasms | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C0149931 | Migraine Disorders | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C0006142 | Malignant neoplasm of breast | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C1168401 | Squamous cell carcinoma of the head and neck | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C0678222 | Breast Carcinoma | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C0003873 | Rheumatoid Arthritis | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C0003486 | Aortic Aneurysm | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C1458155 | Mammary Neoplasms | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C0004153 | Atherosclerosis | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C0001418 | Adenocarcinoma | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C0278996 | Malignant Head and Neck Neoplasm | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C0029456 | Osteoporosis | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C0858252 | Breast adenocarcinoma | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C0003850 | Arteriosclerosis | MMP17 | 4326 | matrix metallopeptidase 17 | Q9ULZ9 |
C0003850 | Arteriosclerosis | CLEC4E | 26253 | C-type lectin domain family 4 member E | Q9ULY5 |
C0022568 | Keratitis | CLEC4E | 26253 | C-type lectin domain family 4 member E | Q9ULY5 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024